BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 208 filers reported holding BRIDGEBIO PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,480 | -35.5% | 58,416 | -21.2% | 0.00% | -33.3% |
Q1 2024 | $2,293 | -16.8% | 74,160 | +8.6% | 0.00% | -25.0% |
Q4 2023 | $2,757 | +117.6% | 68,297 | +42.1% | 0.00% | +100.0% |
Q3 2023 | $1,267 | +68.0% | 48,046 | +9.6% | 0.00% | +100.0% |
Q2 2023 | $754 | -18.2% | 43,849 | -21.2% | 0.00% | 0.0% |
Q1 2023 | $922 | +67.3% | 55,612 | -23.1% | 0.00% | 0.0% |
Q4 2022 | $551 | -99.9% | 72,286 | -0.0% | 0.00% | 0.0% |
Q3 2022 | $719,000 | +9.6% | 72,312 | +0.1% | 0.00% | 0.0% |
Q2 2022 | $656,000 | -10.6% | 72,215 | -0.1% | 0.00% | 0.0% |
Q1 2022 | $734,000 | -75.8% | 72,299 | -60.2% | 0.00% | -66.7% |
Q4 2021 | $3,030,000 | -60.4% | 181,647 | +11.2% | 0.00% | -62.5% |
Q3 2021 | $7,656,000 | -57.6% | 163,352 | -44.8% | 0.01% | -57.9% |
Q2 2021 | $18,049,000 | +4.6% | 296,079 | +5.7% | 0.02% | 0.0% |
Q1 2021 | $17,263,000 | +20.4% | 280,245 | +38.9% | 0.02% | +18.8% |
Q4 2020 | $14,342,000 | +382.2% | 201,689 | +154.5% | 0.02% | +300.0% |
Q3 2020 | $2,974,000 | +15.0% | 79,256 | 0.0% | 0.00% | +33.3% |
Q2 2020 | $2,585,000 | +57.0% | 79,256 | +39.5% | 0.00% | +50.0% |
Q1 2020 | $1,647,000 | +135.0% | 56,800 | +184.0% | 0.00% | +100.0% |
Q4 2019 | $701,000 | +84.5% | 20,000 | +13.0% | 0.00% | – |
Q3 2019 | $380,000 | – | 17,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $60,317,000 | 40.05% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $308,746,000 | 6.20% |
M28 Capital Management LP | 513,300 | $5,102,000 | 5.33% |
GREAT POINT PARTNERS LLC | 1,050,000 | $10,437,000 | 2.51% |
Octagon Capital Advisors LP | 933,743 | $9,281,000 | 1.60% |
HHLR ADVISORS, LTD. | 5,362,014 | $53,298,000 | 1.40% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $264,613,000 | 1.22% |
Cormorant Asset Management, LP | 1,469,179 | $14,604,000 | 1.02% |
Fernwood Investment Management, LLC | 204,550 | $2,033,000 | 0.86% |
TANG CAPITAL MANAGEMENT LLC | 585,424 | $5,819,000 | 0.71% |